Revised recommendations concerning palivizumab prophylaxis for respiratory syncytial virus (RSV)

被引：0

作者：

Lina Bollani

Eugenio Baraldi

Gaetano Chirico

Andrea Dotta

Marcello Lanari

Antonello Del Vecchio

Paolo Manzoni

Antonio Boldrini

Piermichele Paolillo

Sandra Di Fabio

Luigi Orfeo

Mauro Stronati

Costantino Romagnoli

机构：

[1] Unità di Neonatologia,Division of Neonatology, Department of Pediatrics

[2] Patologia Neonatale e Terapia Intensiva,undefined

[3] Policlinico S. Matteo,undefined

[4] U.O.C. Terapia Intensiva e patologia neonatale,undefined

[5] A.O. Padova,undefined

[6] U.O. C. Neonatologia e Terapia Intensiva neonatale,undefined

[7] A.O. Spedali civili,undefined

[8] U.O.C. Terapia intensiva neonatale,undefined

[9] Ospedale pediatrico Bambino Gesù,undefined

[10] U.O. Pediatria E Neonatologia ,undefined

[11] Ospedale Nuovo S. Maria della Scaletta,undefined

[12] U.O. Utin e Neonatologia,undefined

[13] Azienda Ospedaliera di Venere e Giovanni XXIII,undefined

[14] U.O. Neonatologia e TIN ospedaliera,undefined

[15] Azienda Ospedaliera OIRM-S. Anna,undefined

[16] U.O. Nido,undefined

[17] Patologia Neonatale e Terapia Intensiva Neonatale,undefined

[18] Ospedale Santa Chiara,undefined

[19] U.O. Divisione di Neonatologia,undefined

[20] Policlinico Caslino,undefined

[21] U.O. Neonatologia,undefined

[22] Presidio Ospedaliero S. Salvatore,undefined

[23] U.O. Nido,undefined

[24] Patologia Neonatale e Terapia Intensiva Neonatale,undefined

[25] Azienda Ospedaliera G. Rummo,undefined

[26] Unità di Neonatologia,undefined

[27] Patologia Neonatale e Terapia Intensiva,undefined

[28] Ospedale Policlinico S. Matteo,undefined

[29] U.O.C. Neonatologia,undefined

[30] Policlinico Universitario A. Gemelli,undefined

[31] Catholic University S.H.,undefined

来源：

Italian Journal of Pediatrics | / 41卷

关键词：

Respiratory Syncytial Virus; Down Syndrome; Bronchiolitis; Respiratory Syncytial Virus Infection; Esophageal Atresia;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

Respiratory Syncytial Virus infections are one of the leading causes of severe respiratory diseases that require hospitalization and, in some cases, intensive care. Once resolved, there may be respiratory sequelae of varying severity. The lack of effective treatments for bronchiolitis and the lack of vaccines for RSV accentuate the role of prevention in decreasing the impact of this disease.

引用

共 50 条

[1] Revised recommendations concerning palivizumab prophylaxis for respiratory syncytial virus (RSV)
Bollani, Lina
Baraldi, Eugenio
Chirico, Gaetano
Dotta, Andrea
Lanari, Marcello
Del Vecchio, Antonello
Manzoni, Paolo
Boldrini, Antonio
Paolillo, Piermichele
Di Fabio, Sandra
Orfeo, Luigi
Stronati, Mauro
Romagnoli, Costantino
[J]. ITALIAN JOURNAL OF PEDIATRICS, 2015, 41
[2] Effects of palivizumab prophylaxis on respiratory syncytial virus (RSV) infections in Montenegro
Lekic, Envera
Dragas, Ljubinka
Nikcevic, Drasko
Lekic, Jasmina
Dedic, Ana
Sulovic, Ljiljana
[J]. TURKISH JOURNAL OF PEDIATRICS, 2024, 66 (02) : 161 - 170
[3] Review of palivizumab in the prophylaxis of respiratory syncytial virus (RSV) in high-risk infants
Mejias, Asuncion
Ramilo, Octavio
[J]. BIOLOGICS-TARGETS & THERAPY, 2008, 2 (03): : 433 - 439
[4] Palivizumab prophylaxis for respiratory syncytial virus (RSV) in infants with cystic fibrosis (CF) and respiratory illness hospitalizations
Bjornson, Candice
Chan, Parco
Li, Abby
Paes, Bosco
Lanctot, Krista
Mitchell, Ian
[J]. EUROPEAN RESPIRATORY JOURNAL, 2015, 46
[5] Clinical consensus on respiratory syncytial virus (RSV) infection prophylaxis and the use of palivizumab in paediatric cardiology
Medrano Lopez, C.
Garcia-Guereta, L.
Fernandez Pineda, L.
Malo Concepcion, P.
Maroto Alvaro, E.
Santos de Soto, J.
Lirio Casero, J.
Suarez Cabrera, P.
Caballero Martinez, F.
[J]. ANALES DE PEDIATRIA, 2010, 72 (06): : 432 - 432
[6] Emotional and time costs of respiratory syncytial virus prophylaxis: Comparing palivizumab to RSV-IG
Robbins, JM
Tilford, JM
Gillaspy, SR
Simpson, DD
Wheeler, JG
Shaw, JL
Jacobs, RF
[J]. PEDIATRIC RESEARCH, 2000, 47 (04) : 221A - 221A
[7] Respiratory syncytial virus (RSV) immune globulin and palivizumab for prevention of RSV infection
Robinson, RF
Nahata, MC
[J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2000, 57 (03) : 259 - 264
[8] Respiratory syncytial virus: Early palivizumab prophylaxis in the NICU
Bonaparte, J
Wu, SY
Pyati, S
Wilks, A
[J]. PEDIATRIC RESEARCH, 2002, 51 (04) : 270A - 270A
[9] Efficacy and Safety of Palivizumab as a Prophylaxis for Respiratory Syncytial Virus (RSV) Disease: An Updated Systemic Review and MetaAnalysis
El-Atawi, Khaled
De Luca, Daniele
Ramanathan, Ranagasamy
Luna, Manuel Sanchez
Alsaedi, Saad
Wahab, Muzafar Gani Abdul
Hamdi, Moataz
Saleh, Maysa
[J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (12)
[10] Palivizumab prophylaxis in patients admitted to the pediatric intensive care unit (PICU) with respiratory syncytial virus (RSV).
Feller, AE
Morrison, WE
Straumanis, JP
[J]. CRITICAL CARE MEDICINE, 2005, 33 (12) : A92 - A92

← 1 2 3 4 5 →